WHO issues strong recommendation against drug Trump took to try to prevent coronavirus infection
By Kayla Rivas
article
An expert panel advising the World Health Organization (WHO) has issued a strong recommendation against using hydroxychloroquine to treat
Guidance
published in the British Medical Journal this week draws on findings from six trials with over 6,000 participants, and "high certainty evidence" found that the anti-malarial drug "had a small or no effect" on deaths and hospital admissions, while "moderate certainty evidence" found little effect on lab-confirmed SARS-CoV-2 infection.
"The panel considers that this drug is no longer a research priority and that resources should rather be oriented to evaluate other more promising drugs to prevent COVID," the guidance reads. The recommendations apply to anyone without COVID-19, whether or not they were exposed to the virus.